| Application no. and date | 21187414.4 (espacenet) (Federated) (European Patent Register), 20151223 | | Patent/reg. no. and date | DK/EP 3960735, 20230913 | | Publication date | 20220302 | | Priority no. and date | US 201462096748 P, 20141224 | | EP pub. no. and date |
EP 3960735 20220302 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US,
Institute Of Organic Chemistry
And Biochemistry As CR, V.V.I., Flemingovo nam. 2
16610 Praha 6, CZ | | Applicant ref. no. | | | Inventor | JANSA, Petr,
Foster City, US,
SIMON, Petr,
Praha, CZ,
LANSDON, Eric,
Foster City, US,
HU, Yunfeng Eric,
Foster City, US,
BASZCZYNSKI, Ondrej,
Praha, CZ,
DEJMEK, Milan,
Praha, CZ,
MACKMAN, Richard L.,
Foster City, US | | Representative | | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61P 31/18 (2006.01) , C07D 239/94 (2006.01) , C07D 401/12 (2006.01) | | Title | QUINAZOLINE DERIVATIVES USED TO TREAT HIV | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
